What's in Store?

A New Jersey startup is offering parents-to-be testing to determine whether their embryos may have an increased risk of developing diseases like diabetes, hypertension, or breast cancer, the Asbury Park Press reports. But such testing, it notes, raises ethical concerns.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.